Perspective Therapeutics (CATX) Property, Plant & Equipment (Net) (2011 - 2026)
Powered by 
Analysis
Perspective Therapeutics (CATX) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 8.55 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 5.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 1.67 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 5.46 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 2.06 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 2.99 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 11.32 Mn |
| 10 | Perspective Therapeutics | 361.95 Mn | 361.95 Mn | - | 107.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.80 Mn |
| Mar 31, 2026 | 92.48 Mn |
| Dec 31, 2025 | 76.60 Mn |
| Sep 30, 2025 | 64.35 Mn |
| Jun 30, 2025 | 62.60 Mn |
| Mar 31, 2025 | 61.25 Mn |
| Dec 31, 2024 | 57.32 Mn |
| Sep 30, 2024 | 43.79 Mn |
| Jun 30, 2024 | 14.75 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 7.01 Mn |
| Jun 30, 2023 | 7.04 Mn |
| Mar 31, 2023 | 6.73 Mn |
| Dec 31, 2022 | 371,000.00 |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 1.98 Mn |
| Mar 31, 2022 | 1.94 Mn |
| Dec 31, 2021 | 1.97 Mn |
| Sep 30, 2021 | 1.95 Mn |